BiVictriX Therapeutics PLC
LSE:BVX
BiVictriX Therapeutics PLC
LSE:BVX
Price:
10
GBX
17.65%
Market Cap:
£8.3m
Balance Sheet
Balance Sheet Decomposition
BiVictriX Therapeutics PLC
BiVictriX Therapeutics PLC
Balance Sheet Decomposition is not available for
BiVictriX Therapeutics PLC
BiVictriX Therapeutics PLC
Balance Sheet
BiVictriX Therapeutics PLC
BiVictriX Therapeutics PLC
Currency: GBP
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Cash Equivalents |
1
|
6
|
3
|
3
|
|
| Cash |
1
|
6
|
3
|
3
|
|
| Total Receivables |
0
|
0
|
1
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
|
| Total Current Assets |
1
|
7
|
4
|
4
|
|
| PP&E Net |
0
|
0
|
1
|
0
|
|
| PP&E Gross |
0
|
0
|
1
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
|
| Total Assets |
1
N/A
|
7
+543%
|
5
-34%
|
4
-5%
|
|
| Liabilities | |||||
| Accounts Payable |
0
|
0
|
0
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
1
-45%
|
1
+5%
|
1
+31%
|
|
| Equity | |||||
| Common Stock |
0
|
1
|
1
|
1
|
|
| Retained Earnings |
1
|
6
|
9
|
11
|
|
| Additional Paid In Capital |
1
|
12
|
12
|
14
|
|
| Total Equity |
0
N/A
|
6
+8 943%
|
4
-37%
|
4
-11%
|
|
| Total Liabilities & Equity |
1
N/A
|
7
+543%
|
5
-34%
|
4
-5%
|
|
| Shares Outstanding | |||||
| Common Shares Outstanding |
66
|
66
|
66
|
83
|
|
Switch to:
Switch to:
See Also
Discover More
